Koya Medical

Koya Medical

Private
Dallas, TexasHealthcare & Life Scienceshttps://www.koyamedical.com

Last Round

VC Round

Nov 15, 2023

Total Funding Raised

$37M

Momentum Score

25 /100

Company Overview

Koya Medical is a healthcare technology company that develops a wearable therapeutic device for active compression, offering innovative treatments for venous diseases and lymphedema through personalized care and a sensor-based closed-loop system.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

active compression therapywearable compression therapylymphedema treatmentnon-pneumatic compressionvenous disease treatmentmedical wearablesdurable medical equipmentDMElymphedema pumpat-home medical devicemedical device reimbursementcompression garmentFDA 510(k) clearanceHCPCS codesVA medical contract

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Koya Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Koya Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 15, 2023
Series BFeb 3, 2022
Series AJan 14, 2021

Key People

Founding team and executive leadership

Damian Rippole

Chief Operating Officer Financial Officer

Executive Team

Koya Medical Investors

Notable investors and investment history

InvestorRounds
InnerProduct PartnersSeries A
Aphelion CapitalSeries A
Arboretum VenturesSeries B, Series A
Scientific Health DevelopmentSeries A, Series B
OrbiMedVC Round
Zühlke VenturesSeries A
Cadence Healthcare VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2026

    Will present at the Piper Sandler Healthcare Conference on March 16, 2026.

  • Mar 1, 2026

    Flagship Dayspring® wearable compression system receives FDA clearance.

Koya Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Koya Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Koya Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas
Employee Range174
Year Founded2018
Last FundingNov 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.